Skip to main content

UroGen Pharma Ltd.

URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001668243

In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding UroGen Pharma Ltd. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of URGN: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders8293+11
Shares14.0M14.1M+92.4K (+0.7%)
Value$213.7M$236.9M+$23.2M (+10.9%)

New holders (16)

Institutions that held UroGen Pharma Ltd. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to URGN in Q3 2021
InstitutionSharesValue% of portfolio
RTW Investments, LP857,464$14.4M0.22%
Great Point Partners LLC750,000$12.6M2.98%
HealthInvest Partners AB75,000$1.26M1.89%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd.25,330$426.0K0.33%
Martingale Asset Management L P17,208$290.0K0.00%
Vivaldi Capital Management, LLC16,650$280.0K0.06%
Jump Financial, LLC10,500$177.0K0.01%
SG Americas Securities, LLC10,318$174.0K0.00%
MetLife Investment Management7,354$123.7K0.00%
Metropolitan Life Insurance Co5,563$93.6K0.00%
Lazard Asset Management LLC3,281$55.0K0.00%
Sterling Investment Advisors, Ltd.2,000$34.0K0.01%
Quantbot Technologies LP800$13.0K0.00%
Berman Capital Advisors, LLC468$7.00K0.00%
Raffa Wealth Management, LLC42$7060.00%
Gerber Kawasaki Wealth & Investment Management8$00.00%

Sold out (5)

Institutions that held UroGen Pharma Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of URGN in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
FMR LLC47,603$727.0K
Tudor Investment Corp Et Al25,048$382.0K
Susquehanna Fundamental Investments, LLC21,831$333.0K
Squarepoint Ops LLC21,554$329.0K
Mirae Asset Global Investments Co., Ltd.363$6.00K